Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.745
+0.005 (0.29%)
Jan 22, 2025, 2:15 PM EST - Market open
Aytu BioPharma Employees
Aytu BioPharma had 102 employees as of June 30, 2024. The number of employees decreased by 48 or -32.00% compared to the previous year.
Employees
102
Change (1Y)
-48
Growth (1Y)
-32.00%
Revenue / Employee
$781,951
Profits / Employee
-$61,275
Market Cap
10.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
AYTU News
- 16 days ago - Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Accesswire
- 7 weeks ago - Aytu BioPharma Disclosure Notification - Accesswire
- 2 months ago - Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM) - Accesswire
- 2 months ago - Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results - Accesswire
- 2 months ago - Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024 - Accesswire
- 3 months ago - Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit - Accesswire
- 4 months ago - Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada - Accesswire